EXOGENE
Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well as safe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
EXOGENE
Social Links:
Industry:
Artificial Intelligence Biotechnology Life Science Pharmaceutical
Founded:
2019-11-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.exogene.co.uk
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Core Biogenesis
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Numerate
Numerate seeks to overcome major challenges in drug discovery by applying novel machine-learning algorithms, at cloud scale, to drug design.
Soltego
Soltego is a biotechnology company leveraging the skin’s pigmentation power for therapeutic and aesthetic applications.
Spring Discovery
Spring Discovery accelerates the discovery of therapies for aging by targeting the biological processes of aging itself.
Current Advisors List
Current Employees Featured
Founder
Investors List
Jude Gomila
Jude Gomila investment in Pre Seed Round - Exogene
Nadav Rosenberg
Nadav Rosenberg investment in Pre Seed Round - Exogene
R42 Group
R42 Group investment in Pre Seed Round - Exogene
Stefano Bernardi
Stefano Bernardi investment in Pre Seed Round - Exogene
KQ Labs
KQ Labs investment in Pre Seed Round - Exogene
Selvedge Venture
Selvedge Venture investment in Pre Seed Round - Exogene
Entrepreneur First
Entrepreneur First investment in Pre Seed Round - Exogene
Entrepreneur First
Entrepreneur First investment in Convertible Note - Exogene
Official Site Inspections
http://www.exogene.co.uk
- Host name: 495654.cloudwaysapps.com
- IP address: 167.99.88.128
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Exogene"
Exogene – Unlocking curative TCR-based therapies
Exogene is a techbio startup using deep learning to unlock the discovery of innovative ... PhD in Molecular and Computational Oncology from the University of Oxford and has previously …See details»
EXOGENE LIMITED overview - Find and update company …
GOV.UK Find and update company information Companies House does not verify the accuracy of the information filed (link opens a new window) ... More for EXOGENE LIMITED (12293407) …See details»
Exogene - Crunchbase Company Profile & Funding
Organization. Exogene . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... exogene.co.uk/ 66,329; …See details»
Exogene - LinkedIn
Exogene is a venture-backed biotechnology company combining generative AI and high-throughput lab experiments to design high-affinity, cancer-specific T-cell receptors (TCRs) and develop TCR-based ...See details»
EXOGENE LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for EXOGENE LIMITED of LONDON. Get the latest business insights from Dun & Bradstreet.See details»
Exogene raises $2 million for its AI platform to discover cell ...
Oxford, UK, 28th April 2022 / Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, today announces that it has raised US$2 million in funding to develop its …See details»
Exogene - VentureRadar
Exogene is a biotechnology company enabling the discovery of T-cell-receptor (TCR)-based cell therapies to tackle solid tumors and reverse immune aging, by combining artificial intelligence …See details»
Exogene - Creative Destruction Lab
Exogene is a biotechnology startup accelerating the discovery of T-cell-receptor(TCR)-based cell therapies for otherwise untreatable solid tumors. They are building a machine learning platform to comprehensively screen TCRs …See details»
Exogene - Products, Competitors, Financials, Employees, …
Exogene Exogene is a biotechnology startup accelerating the discovery of T-cell-receptor(TCR)-based cell therapies for otherwise untreatable solid tumors. They are building a machine …See details»
Exogene - Overview, News & Similar companies | ZoomInfo.com
Who is Exogene. Exogene is a venture-backed biotechnology company enabling the discovery of T-cell-receptor (TCR)-based cell therapies to tackle solid tumors and r everse immune aging, …See details»
Exogene - 2025 Company Profile - Tracxn
Mar 29, 2025 Exogene - Developer of AI-powered T-cell-receptor-based immunotherapies for cancer treatment. Raised a total funding of $2M over 1 round from 8 investors. ...See details»
Exogene (company) | Nordic 9
Exogene.co.uk . See something wrong or missing? Let us know. Offices: London. Industry: AI (big data) Biotech Health services Software Services. Business model: B2B. Exogene is a …See details»
Exogene Ltd. Overview | SignalHire Company Profile
[email protected]: Exogene Ltd. industries Biotech: Headquarters Location: Innovation Building, Old Road Campus, 696 Roosevelt Drive, Oxford, Oxfordshire, OX3 7FZ GB …See details»
Exogene Announces Strategic Collaboration with Immunocore To …
4th March, 2024. Oxford, UNITED KINGDOM. Exogene, a pioneer in the use of generative artificial intelligence (AI) for T-cell receptor (TCR) engineering, has entered into a research …See details»
Introducing Exogene — BioEscalator
Jun 1, 2021 Exogene's artificial intelligence platform rapidly screens billions of TCRs from patients in order to computationally identify and create TCRs that can target and destroy …See details»
Exogene - inaitoday.com
Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening. ... Founders / Management. Andrea …See details»
Exogene | VentureRadar
Exogene is a biotechnology company enabling the discovery of T-cell-receptor (TCR)-based cell therapies to tackle solid tumors and reverse immune aging, by combining artificial intelligence …See details»
Exogene Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Exogene. See Exogene company profile and funding data.See details»
News – Exogene
Apr 28, 2022 Continue Reading Exogene Announces Strategic Collaboration with Immunocore To Engineer T-Cell Receptors Using Artificial Intelligence. ... Post category: Oxford, UK, 28th …See details»
Events in Gaza a ‘live-streamed genocide’, High Court told
22 hours ago The conflict in Gaza is a “live-streamed genocide”, the High Court has been told.. Al-Haq, a Palestinian human rights organisation, is bringing legal action against the …See details»